Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury
Advanced Healthcare Materials · 2024-06 · 13 (16)
DOI: 10.1002/adhm.202303267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.03.2024. Verfasst von Haipeng Tan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, 20032, P. R. China. Hauptthemen laut MEDLINE: CD47 Antigen, Myocardial Reperfusion Injury, Macrophages, c-Mer Tyrosine Kinase. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, State Key Clinical Specialty Construction Project, Shanghai Rising-Star Program.
Abstract (Originalsprache)
Efferocytosis, mediated by the macrophage receptor MerTK (myeloid‐epithelial‐reproductive tyrosine kinase), is a significant contributor to cardiac repair after myocardial ischemia‐reperfusion (MI/R) injury. However, the death of resident cardiac macrophages (main effector cells), inactivation of MerTK (main effector receptor), and overexpression of “do not eat me” signals (brake signals, such as CD47), collectively lead to the impediment of efferocytosis in the post‐MI/R heart. To date, therapeutic strategies targeting individual above obstacles are relatively lacking, let alone their effectiveness being limited due to constraints from the other concurrent two. Herein, inspired by the application research of chimeric antigen receptor macrophages (CAR‐Ms) in solid tumors, a genetically modified macrophage‐based synergistic drug delivery strategy that effectively challenging the three major barriers in an integrated manner is developed. This strategy involves the overexpression of exogenous macrophages with CCR2 (C‐C chemokine receptor type 2) and cleavage‐resistant MerTK, as well as surface clicking with liposomal PEP‐20 (a CD47 antagonist). In MI/R mice model, this synergistic strategy can effectively restore cardiac efferocytosis after intravenous injection, thereby alleviating the inflammatory response, ultimately preserving cardiac function. This therapy focuses on inhibiting the initiation and promoting active resolution of inflammation, providing new insights for immune‐regulatory therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, 20032, P. R. China.
- National Clinical Research Center for Interventional Medicine and Shanghai Clinical Research Center for Interventional Medicine, Shanghai, 200032, P. R. China.
- Key Laboratory of Viral Heart Diseases, National Health Commission, Shanghai, 20032, P. R. China.
- Key Laboratory of Smart Drug Delivery, School of Pharmacy, Fudan University, Ministry of Education, 826 Zhangheng Road, Pudong New Area, Shanghai, 201210, P. R. China.
ORCID-Profile: Zheyong Huang
Förderung
- National Natural Science Foundation of China
- State Key Clinical Specialty Construction Project
- Shanghai Rising-Star Program
- Shanghai Clinical Research Center for Interventional Medicine
Zitieren
APA
Tan, H., Li, W., Pang, Z., Weng, X., Gao, J., Chen, J., Wang, Q., Li, Q., Yang, H., Dong, Z., Wang, Z., Zhu, G., Tan, Y., Fu, Y., Han, C., Cai, S., Qian, J., Huang, Z., Song, Y., & Ge, J. (2024). Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury. Advanced Healthcare Materials, 13(16). https://doi.org/10.1002/adhm.202303267
Vancouver
Tan H, Li W, Pang Z, Weng X, Gao J, Chen J, et al. Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury. Advanced Healthcare Materials. 2024;13(16). doi:10.1002/adhm.202303267
BibTeX
@article{Tan2024,
author = {Tan, Haipeng and Li, Weiyan and Pang, Zhiqing and Weng, Xueyi and Gao, Jinfeng and Chen, Jing and Wang, Qiaozi and Li, Qiyu and Yang, Hongbo and Dong, Zheng and Wang, Zhengmin and Zhu, Guangrui and Tan, Yiwen and Fu, Yuyuan and Han, Chengzhi and Cai, Shiteng and Qian, Juying and Huang, Zheyong and Song, Yanan and Ge, Junbo},
title = {Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {16},
doi = {10.1002/adhm.202303267}
}
EUVIMED